Zymeworks, Inc. (ZYME)
25.14
-0.70
(-2.69%)
USD |
NASDAQ |
Nov 18, 12:22
Zymeworks Price : 25.14 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 26.45 | 26.52 | 25.53 | 25.84 | 569926.0 |
| Nov 16, 2026 | 27.47 | 27.74 | 26.35 | 26.45 | 969741.0 |
| Nov 13, 2026 | 26.47 | 26.75 | 25.82 | 26.24 | 774983.0 |
| Nov 12, 2026 | 28.92 | 29.03 | 26.43 | 26.47 | 1.332M |
| Nov 11, 2026 | 31.80 | 31.94 | 28.92 | 29.07 | 980379.0 |
| Nov 10, 2026 | 31.15 | 31.97 | 30.64 | 31.46 | 1.688M |
| Nov 09, 2026 | 30.00 | 30.88 | 29.66 | 30.81 | 1.164M |
| Nov 06, 2026 | 28.74 | 29.92 | 28.40 | 29.63 | 907970.0 |
| Nov 05, 2026 | 30.85 | 30.91 | 28.72 | 28.74 | 1.224M |
| Nov 04, 2026 | 30.79 | 31.49 | 30.51 | 30.94 | 1.046M |
| Nov 03, 2026 | 29.41 | 30.40 | 29.20 | 30.13 | 2.520M |
| Nov 02, 2026 | 28.69 | 29.28 | 28.27 | 28.99 | 1.176M |
| Oct 30, 2026 | 28.81 | 29.02 | 28.26 | 28.61 | 2.880M |
| Oct 29, 2026 | 29.20 | 29.50 | 28.53 | 28.71 | 806234.0 |
| Oct 28, 2026 | 28.54 | 29.46 | 28.54 | 28.90 | 833159.0 |
| Oct 27, 2026 | 28.21 | 29.18 | 27.96 | 28.85 | 1.126M |
| Oct 26, 2026 | 28.36 | 28.59 | 27.59 | 28.37 | 833942.0 |
| Oct 23, 2026 | 28.77 | 28.77 | 27.28 | 28.22 | 1.124M |
| Oct 22, 2026 | 28.12 | 28.97 | 27.99 | 28.44 | 757350.0 |
| Oct 21, 2026 | 26.96 | 28.27 | 26.90 | 28.12 | 1.319M |
| Oct 20, 2026 | 25.76 | 27.20 | 25.71 | 26.91 | 3.130M |
| Oct 19, 2026 | 25.06 | 25.74 | 25.06 | 25.54 | 2.040M |
| Oct 16, 2026 | 25.67 | 25.86 | 24.94 | 25.03 | 632910.0 |
| Oct 15, 2026 | 25.19 | 26.21 | 25.18 | 25.75 | 751932.0 |
| Oct 14, 2026 | 25.00 | 25.20 | 24.60 | 24.77 | 558779.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 288.69 |
| Faeth Therapeutics, Inc. | 8.85 |
| ACADIA Pharmaceuticals, Inc. | 18.21 |
| Alnylam Pharmaceuticals, Inc. | 152.40 |
| Anika Therapeutics, Inc. | 13.30 |
Price Related Metrics
| PE Ratio | 48.15 |
| PS Ratio | 7.073 |
| Price to Book Value | 6.983 |
| Earnings Yield | 2.08% |
| Market Cap | 1.803B |
| Operating PE Ratio | 42.61 |
| Normalized PE Ratio | 47.89 |